1. Histone deacetylase 6 as a novel promising target to treat cardiovascular disease.
- Author
-
Wu, Ya‐Xi, Li, Bing‐Qian, Yu, Xiao‐Qian, Liu, Yu‐Lin, Chui, Rui‐Hao, Sun, Kai, Geng, Dian‐Guang, and Ma, Li‐Ying
- Subjects
HISTONE deacetylase ,CARDIOVASCULAR diseases ,CARDIAC hypertrophy ,MYOCARDIAL infarction ,PULMONARY hypertension - Abstract
Histone deacetylase 6 (HDAC6) belongs to a class of epigenetic targets that have been found to be a key protein in the association between tumors and cardiovascular disease. Recent studies have focused on the crucial role of HDAC6 in regulating cardiovascular diseases such as atherosclerosis, myocardial infarction, myocardial hypertrophy, myocardial fibrosis, hypertension, pulmonary hypertension, and arrhythmia. Here, we review the association between HDAC6 and cardiovascular disease, the research progress of HDAC6 inhibitors in the treatment of cardiovascular disease, and discuss the feasibility of combining HDAC6 inhibitors with other therapeutic agents to treat cardiovascular disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF